DEVINDERPAL SINGH RANDHAWA MD NPI 1225072648

NPI Information

  • NPI: 1225072648
  • Provider Name: DEVINDERPAL SINGH RANDHAWA, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 462 GRIDER ST
    BUFFALO, NY
    ZIP 14215
  • Phone: (716) 898-5660

Map and Directions

Get Directions

NPI Details

Devinderpal Singh Randhawa, MD is a hematology and oncology internal medicine in Buffalo, NY with 25 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Devinderpal Singh Randhawa, MD NPI is 1225072648. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

462 GRIDER ST
BUFFALO, NY
ZIP 14215-098
Phone: (716) 898-5660
Fax: (716) 961-6969

The NPI 1225072648 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Red blood count, automated test (HCPCS:85045)
  • Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99426)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Urinalysis, manual test (HCPCS:81002)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)

The enumeration date for this NPI number is 6/15/2006 and was last updated on 8/29/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0000XInternal MedicineHematologyMD61171493WASHINGTONNo
2207RX0202XInternal MedicineMedical OncologyMD61171493WASHINGTONNo
3207RH0003XInternal MedicineHematology & OncologyMD61171493WASHINGTONYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.